Filter your results
- 2
- 2
- 2
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infectionJournal of Hepatology, 2016, 64 (2), pp.292-300. ⟨10.1016/j.jhep.2015.09.024⟩
Journal articles
hal-01659111v1
|
|||
|
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort studyAlimentary Pharmacology & Therapeutics (Suppl), 2020, 52 (3), pp.500-512. ⟨10.1111/apt.15901⟩
Journal articles
hal-03933002v1
|